CellVax Therapeutics Announces FDA Clearance of IND Application for FK-PC101, a Novel Personalized Cancer Immunotherapy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced that its sponsor client, CellVax.
Randomized clinical trials of ICIs have traditionally excluded immunocompromised individuals, but emerging evidence suggests the drugs have the potential to treat advanced cancers in transplant recipients. Clinicians face a challenge in the use of immune checkpoint inhibitor therapy in organ transplant recipients because of their need for immunosuppression.
CS-003: ADSTILADRIN in Patients With High Grade, BCG Unresponsive NMIBC urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.